| Followers | 19 |
| Posts | 6550 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Monday, December 28, 2020 6:55:47 AM
[t][/t]The amusing fact is that The itsy bitsy spider will not BEE spinning its web around the opportunities of a product line like CV SCIENCES CANTINE products. BTW. The application you sent on a similar PATENT as Cantine’s will not pass muster. The SHAM company located in a flat in New York City is used ONLY to infringe on other companies patents, is frivolous in nature YQU Understand. Must be eating some black widows to a sense of ENVY of CV SCIENCES CANTINE success. Lmao Do U wonder why the sham company filed on April 2017 and it hasn’t been approved? Because we now have the PATENT YQU Understand. IMHO Have Mercy Wolf Ahooooooo
Dr. Joong J Fang Said: We have the MEATS...
https://www.bloomberg.com/press-releases/2020-04-06/cv-sciences-inc-receives-notice-of-patent-allowance-from-uspto-for-proprietary-cannabidiol-cbd-and-nicotine-formulation-for
WQLFPACK Said:
https://4gunner.com/ukraine-press-release-about-joe-biden/
WQLF Says;
WQLFMAN JACK Said;
CVSI-007/Cantine? Here's a related Darth Yodeling post
Dr. Joong J Fang Said: We have the MEATS...
https://www.bloomberg.com/press-releases/2020-04-06/cv-sciences-inc-receives-notice-of-patent-allowance-from-uspto-for-proprietary-cannabidiol-cbd-and-nicotine-formulation-for
WQLFPACK Said:
https://4gunner.com/ukraine-press-release-about-joe-biden/
WQLF Says;
WQLFMAN JACK Said;
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
